글로벌 면역형광 시장 – 2028년까지의 산업 동향 및 예측

면역형광 시장의 시장 분석 및 통찰력

면역형광 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 5.4%의 CAGR로 성장할 것으로 분석합니다.

면역형광은 중간 크기의 필라멘트와 같은 구조를 시각화하는 데 사용되는 기술로 정의되며, 다양한 미생물 샘플에 형광 현미경과 함께 광학 현미경을 활용합니다. 다양한 미생물 샘플에는 조직과 세포 연구가 포함됩니다. 이 연구는 치료제 개발 및 진단과 같은 다양한 질병에 대한 임상 연구에 이상적입니다.

다양한 만성 질환을 앓고 있는 환자의 증가와 의료 인프라에 발생하는 막대한 지출, 그리고 의료의 질 향상은 면역형광 시장 성장을 견인하는 중요한 요인입니다. 또한, 다양한 제조업체와 조직이 연구 개발을 강화하는 데 집중함에 따라 동일한 분야에 많은 지출이 발생하고 시장의 전반적인 성장도 높아집니다. 그러나 면역형광 및 구현을 위한 도구와 관련된 높은 수준의 재정적 비용과 다양한 세계 지역 간의 거래에 대한 다양한 불리한 규정의 존재는 시장 성장을 방해할 것으로 추정됩니다.

성장하는 의료 보험 및 기타 의료 보상 시설은 시장에 수익성 있는 기회를 창출할 것으로 예상됩니다. 반면, 이 기술을 사용한 교차 반응성과 낮은 신호 강도에 대한 우려는 시장 성장에 도전할 가능성이 있습니다.

This immunofluorescence market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research immunofluorescence market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Immunofluorescence Market Scope and Market Size

Immunofluorescence market is segmented on the basis of product, type, disease, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product, the market is segmented into reagents, instruments, antibodies, kits and consumables and accessories. The reagents are sub-segmented into stains and dyes, media and sera, fixatives, buffers, probes, solvents and others. The instruments are sub-segmented into microscopes and imaging analysis systems. The antibodies are sub-segmented into primary antibodies and secondary antibodies.
• On the basis of type, the immunofluorescence market is segregated into secondary/indirect immunofluorescence, primary/direct immunofluorescence and micro immunofluorescence. The secondary/indirect immunofluorescence are sub-segmented into salt split technique, antigenic mapping method and double staining method.
• On the basis of disease, the market is segmented into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases and others.
• On the basis of application, the immunofluorescence market is segmented into clinical research and laboratory diagnostics.
• On the basis of end-user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and diagnostic centers and CROs.

Immunofluorescence Market Country Level Analysis

Immunofluorescence market is analyzed and market size insights and trends are provided by product, type, disease, application and end-user as referenced above.

The countries covered in the immunofluorescence market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to growing incidences of chronic and infectious diseases, favorable government funding opportunities, and the presence of major key players in the region within the region. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period of 2021 to 2028 owing to the large untapped potential market, improving healthcare infrastructure and growing healthcare spending.

The country section of the immunofluorescence market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

Immunofluorescence market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for immunofluorescence market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immunofluorescence market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Immunofluorescence Market Share Analysis

Immunofluorescence market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to immunofluorescence market.

면역형광 시장 보고서에서 다루는 주요 기업은 Trinity Biotech Ireland, Biocare Medical, LLC, Abcam plc, Bio-Rad Laboratories, Inc, PerkinElmer Inc, Merck KGaA, Inova Diagnostics, Inc, Cell Signaling Technology, Inc, Sino Biological Inc, Beckman Coulter, Inc, Vector Laboratories, Novus Biologicals, Svar Life Science AB, Olympus Corporation, Leica Microsystems, Enzo Life Sciences, Inc, Agilent Technologies, Inc, Zyagen; BD, TCS Biosciences Ltd. 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-50208